scispace - formally typeset
S

Shiliang Zhang

Researcher at National Institute on Drug Abuse

Publications -  32
Citations -  2532

Shiliang Zhang is an academic researcher from National Institute on Drug Abuse. The author has contributed to research in topics: Ventral tegmental area & Glutamate receptor. The author has an hindex of 17, co-authored 26 publications receiving 1770 citations.

Papers
More filters
Journal ArticleDOI

Single rodent mesohabenular axons release glutamate and GABA

TL;DR: An unanticipated type of VTA neuron is revealed that cotransmits glutamate and GABA and provides the majority of mesohabenular inputs in LHb neurons.
Journal ArticleDOI

Dopaminergic and glutamatergic microdomains in a subset of rodent mesoaccumbens axons

TL;DR: A complex type of signaling by mesoaccumbens fibers is revealed in which dopamine and glutamate can be released from the same axons, but are not normally released at the same site or from theSame synaptic vesicles.
Journal ArticleDOI

VTA glutamatergic inputs to nucleus accumbens drive aversion by acting on GABAergic interneurons

TL;DR: The ventral tegmental area (VTA) is best known for its dopamine neurons, some of which project to nucleus accumbens (nAcc), but the VTA also has glutamatergic neurons that project to nAcc, and the mesoaccumbens glutamatorgic pathways are reported on, which are the first glutamaters to be shown to mediate aversion instead of reward.
Journal ArticleDOI

A glutamatergic reward input from the dorsal raphe to ventral tegmental area dopamine neurons.

TL;DR: Findings indicate that the DR-VGluT3 pathway to VTA utilizes glutamate as a neurotransmitter and is a substrate linking the DR—one of the most sensitive reward sites in the brain—to VTA dopaminergic neurons.